One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!

Mark G. Holladay net worth and biography

Mark Holladay Biography and Net Worth

EVP of Synovus Financial

Holladay joined Columbus Bank and Trust Company in 1974 as a part-time teller and participated in the bank's management trainee program. He also served in the Retail Branch network as assistant manager and branch manager. He was then named Vice President of Commercial Lending in 1984 and Senior Commercial Lending Officer in 1991. Holladay was appointed Senior Vice President of Commercial Lending in 1992. In 1994, he was named Executive Vice President of the Commercial Group, and in 1998 he was promoted to Executive Vice President of Banking/Client Delivery. In 2000, Holladay accepted the role of Executive Vice President and Chief Credit Officer. In 2008, he was named to the role of Executive Vice President and Chief Risk Officer.

Education

BS, Biology, Columbus College
Graduate School of Banking of the South, Louisiana State University
Masters' Program of Banking, Louisiana State University

Affiliations

Immediate Past President - Graduate School of Banking of the South, Louisiana State University
Board Member and Treasurer, Calvary Christian School
Business Improvement District Board, Uptown Columbus
Shared Assessment Advisory Board Member

Summary of Responsibilities
Holladay oversees the company’s enterprise risk management operations and related activities. He is responsible for providing the overall leadership, vision and direction for Enterprise Risk Management. Direct Reports include Compliance, Operational Risk, Credit Review, and the Enterprise Risk Management Department.

What is Mark G. Holladay's net worth?: The estimated net worth of Mark G. Holladay is at least $2.17 million as of August 6th, 2021. Mr. Holladay owns 59,799 shares of Synovus Financial stock worth more than $2,167,714 as of April 25th. This net worth approximation does not reflect any other investments that Mr. Holladay may own. Learn More about Mark G. Holladay's net worth.
How do I contact Mark G. Holladay?: The corporate mailing address for Mr. Holladay and other Synovus Financial executives is 1111 BAY AVENUE SUITE 500, COLUMBUS GA, 31901. Synovus Financial can also be reached via phone at (706) 641-6500 and via email at [email protected]. Learn More on Mark G. Holladay's contact information.
Has Mark G. Holladay been buying or selling shares of Synovus Financial?: Mark G. Holladay has not been actively trading shares of Synovus Financial over the course of the past ninety days. Most recently, Mark G. Holladay sold 1,500 shares of the business's stock in a transaction on Wednesday, December 1st. The shares were sold at an average price of $46.60, for a transaction totalling $69,900.00. Learn More on Mark G. Holladay's trading history.
Who are Synovus Financial's active insiders?: Synovus Financial's insider roster includes Tim Bentsen (Director), Daniel Bishop (EVP), Kevin Blair (CEO), Thomas Dierdorff (EVP), Andrew Gregory, Jr. (CFO), Mark Holladay (EVP), Allan Kamensky (EVP), Joseph Prochaska, Jr. (Director), John Stallworth (Director), and Kessel Stelling (Chairman). Learn More on Synovus Financial's active insiders.
Are insiders buying or selling shares of Synovus Financial?: During the last year, Synovus Financial insiders bought shares 13 times. They purchased a total of 247,856 shares worth more than $5,366,629.73. During the last year, insiders at the bank sold shares 3 times. They sold a total of 26,017 shares worth more than $934,302.38. The most recent insider tranaction occured on January, 24th when Director Tim E Bentsen sold 4,671 shares worth more than $180,394.02. Insiders at Synovus Financial own 0.8% of the company. Learn More about insider trades at Synovus Financial.
Information on this page was last updated on 1/24/2024.

Mark G. Holladay Insider Trading History at Synovus Financial

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/1/2021	Sell	1,500	$46.60	$69,900.00
11/1/2021	Sell	1,500	$47.13	$70,695.00
10/1/2021	Sell	1,500	$44.12	$66,180.00
8/6/2021	Sell	1,500	$43.13	$64,695.00	59,799
7/2/2021	Sell	1,500	$44.28	$66,420.00	61,787
9/6/2019	Sell	5,000	$35.72	$178,600.00	60,289
6/21/2018	Buy	4,000	$25.00	$100,000.00	4,000
2/1/2018	Sell	5,000	$50.16	$250,800.00	52,063
10/27/2016	Sell	6,035	$33.28	$200,844.80	53,967
2/6/2015	Sell	5,400	$27.96	$150,984.00
7/24/2013	Buy	1,500	$3.09	$4,635.00

Mark G. Holladay Buying and Selling Activity at Synovus Financial

Synovus Financial Company Overview

Synovus Financial Corp. operates as the bank holding company for Synovus Bank that provides commercial and consumer banking products and services. It operates through four segments: Community Banking, Wholesale Banking, Consumer Banking, and Financial Management Services. The company's commercial banking services include treasury and asset management, capital market, and institutional trust services, as well as commercial, financial, and real estate lending services. Its consumer banking services comprise accepting customary types of demand and savings deposits accounts; mortgage, installment, and other consumer loans; investment and brokerage services; safe deposit services; automated banking services; automated fund transfers; internet-based banking services; and bank credit and debit card services, including Visa and MasterCard services. The company also offers various other financial services, including portfolio management for fixed-income securities, investment banking, execution of securities transactions as a broker/dealer, trust management, and financial planning services, as well as provides individual investment advice on equity and other securities. The company was founded in 1888 and is headquartered in Columbus, Georgia.

Today's Range

Now: $36.59

$36.18

$36.85

50 Day Range

MA: $37.92

$33.92

$40.06

2 Week Range

Now: $36.59

$24.40

$40.92

Volume

1,253,266 shs

Average Volume

1,513,217 shs

Market Capitalization

$5.36 billion

P/E Ratio

12.53

Dividend Yield

4.15%

Beta

1.4

The World's First "$20 Trillion Drug?"

From Behind the Markets | Ad

Get the name of the stock here >>>